Applications of lentiviral vectors for shRNA delivery and transgenesis
about
Selective gene silencing by viral delivery of short hairpin RNASingle and Multiple Gene Manipulations in Mouse Models of Human CancerThe adaptor protein Disabled-2: new insights into platelet biology and integrin signalingProteomic analysis of PKCγ-related proteins in the spinal cord of morphine-tolerant ratsAttenuated food anticipatory activity and abnormal circadian locomotor rhythms in Rgs16 knockdown miceGene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.A primer on using pooled shRNA libraries for functional genomic screensADAM17 mediates MMP9 expression in lung epithelial cells.LPA(1) -induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cellsEnhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials.Viral bimolecular fluorescence complementation: a novel tool to study intracellular vesicular trafficking pathways.Specific inhibition of SRC kinase impairs malignant glioma growth in vitro and in vivo.A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector.Genetically engineered mouse models in cancer researchMicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis.Lentiviral small hairpin RNA knockdown of macrophage inflammatory protein-1γ ameliorates experimentally induced osteoarthritis in mice.Targeting the cell cycle inhibitor p57Kip2 promotes adult human β cell replication.Strategies for short hairpin RNA delivery in cancer gene therapy.RNAi in the mouse: rapid and affordable gene function studies in a vertebrate system.Targeting eradication of chronic myeloid leukemia using chimeric oncolytic adenovirus to drive IL-24 expression.Quantitative evaluation of first, second, and third generation hairpin systems reveals the limit of mammalian vector-based RNAi.Herpesvirus saimiri-based endothelin-converting enzyme-1 shRNA expression decreases prostate cancer cell invasion and migration.Regulation of Human Adenovirus Replication by RNA Interference.Embryo development, fetal growth and postnatal phenotype of eGFP lambs generated by lentiviral transgenesis.Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors.In Vitro Erythroid Differentiation and Lentiviral Knockdown in Human CD34+ Cells from Umbilical Cord Blood.Effects of lentivirus-mediated endostatin on endothelial progenitor cells.Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke.A novel experimental model for human mixed acinar-ductal pancreatic cancer.Biological effects of lentivirus-mediated shRNA targeting collagen type I on the mesangial cells of rats.Visualization of Stat3 and Stat5 transactivation activity with specific response element dependent reporter constructs integrated into lentiviral gene transfer vectors.
P2860
Q21245112-7982FA06-6E38-4F42-B97A-F625EC781FC6Q26783920-78495183-4F76-491A-A38A-15E8FF6E9367Q28074277-5562D12D-1B80-4CA4-8B4B-1E18D513B19EQ28481707-CCEA4B9F-39AD-4F86-A72E-D90383397A91Q28742089-53627EC4-F1FA-432D-80D9-7E76C64B0961Q33828114-1DC8AD69-3BE1-40A6-AC16-F23EB2032EA7Q34137070-8C9219BF-8D6B-447A-B900-CE7BC086110CQ34558156-54DA3AC6-17DF-4F5F-A6A6-8072A4B5E5A7Q35046383-BE3C7A5D-9B42-4D50-8C22-09917FA643B7Q35142623-C8B2BE83-2BFD-486D-BC1F-CB17029220A1Q35542711-BD4E4C41-863C-48E2-A022-C43660AD48D0Q36077844-1EBDD5CE-7D5B-4146-B3B9-0DADE798AF16Q36293232-4A76ADDB-781F-46F3-B8DC-5498B779096DQ36497718-94C412E1-487D-4D80-B545-D2B54722A2F1Q36983759-2AAAF7C1-DC55-414F-9F53-513EDE2F200AQ37208260-94D13155-E15F-4014-B5D0-8A155C29CC51Q37524219-F72E1416-BC72-4C78-BB6F-2F1A45655AF4Q37598928-60F91BB8-E548-42C9-92BE-51EAE6DD5059Q38268543-44B5367A-C562-4CA1-8D47-676F595BB4D9Q38861342-FAF84E0C-DB12-4C11-9E52-16834055F256Q38918720-B8897CF3-6730-4E93-83B9-F529C8A0C818Q39643724-6685A6C2-81C8-4BDE-A7EF-9E0133835ED4Q40944659-3A01395B-F38A-4BC9-A9F8-FAE32F5ECF73Q42204633-2136C21E-413D-41AF-A325-995103E1FF1AQ42863043-BC9D587B-10B3-43BE-97DA-5C5420DB7123Q45071131-6A0E9A8D-6F6F-4E36-A207-8F2050402019Q45875518-C8D28D01-383B-4364-8F09-41C4E2533A4DQ49011342-F031F94B-7DBD-4819-98BE-B1C3D91C7856Q50141073-CEB770C4-9A95-48D7-9CA1-C31A89FFB92EQ50280084-91D849FD-0851-443B-8D23-2AB638177F1AQ51919034-6ECA884A-EFBA-42F4-AFB8-9C3053C743B6
P2860
Applications of lentiviral vectors for shRNA delivery and transgenesis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Applications of lentiviral vectors for shRNA delivery and transgenesis
@en
Applications of lentiviral vectors for shRNA delivery and transgenesis.
@nl
type
label
Applications of lentiviral vectors for shRNA delivery and transgenesis
@en
Applications of lentiviral vectors for shRNA delivery and transgenesis.
@nl
prefLabel
Applications of lentiviral vectors for shRNA delivery and transgenesis
@en
Applications of lentiviral vectors for shRNA delivery and transgenesis.
@nl
P2860
P1433
P1476
Applications of lentiviral vectors for shRNA delivery and transgenesis
@en
P2093
Inder M Verma
Oded Singer
P2860
P304
P356
10.2174/156652308786848067
P407
P577
2008-12-01T00:00:00Z